MOBILion Systems to Present Advanced Proteomics Capabilities with New PAMAF Operating Mode at US HUPO 2025

CHADDS FORD, Pa., Feb. 13, 2025 /PRNewswire/ — MOBILion Systems, Inc., a leader in separation science innovation, today announced its participation in the 21st Annual US HUPO Conference, taking place February 22-26, 2025, in Philadelphia, PA. MOBILion will showcase its new Parallel Accumulation with Mobility Aligned Fragmentation (PAMAF) operating mode through multiple scientific presentations, demonstrating increased speed and sensitivity of LC-MS analysis for proteomics applications.

MOBILion Presents PAMAF Mode at US HUPO 2025, Advancing Proteomics with Faster, More Sensitive LC-MS Analysis

“Our PAMAF operating mode enables researchers to make more accurate analytical measurements and achieve deeper proteome characterization, supporting scientific discovery in critical areas of human health research,” said Melissa Sherman, Ph.D., CEO of MOBILion Systems. “By replacing quadrupole isolation with high-resolution ion mobility separation, PAMAF generates fragmentation data with 10x higher signal-to-noise and 5x faster speeds than conventional systems.  With essentially 100 percent ion utilization, PAMAF is particularly valuable for sample-limited workflows, including single-cell proteomics applications. MOBILion’s participation at US HUPO 2025 reflects our commitment to advancing proteomics research through innovative separation science.”

Researchers will give presentations demonstrating how PAMAF’s capabilities extend beyond traditional LC-MS approaches, highlighting how it reduces chimeric spectra to improve protein quantification and post-translational modification analysis.

An educational breakfast seminar will feature Prof. Birgit Schilling, from The Buck Institute for Research on Aging, presenting research on succinylation levels in a sirtuin-5 knockout mouse model for chronic kidney disease (CKD). Using MOBILion’s PAMAF mode, Prof. Schilling’s team identified hundreds of differentially regulated succinylation sites that may contribute to phenotypic protection against kidney diseases.

Scientific Program Details:

Oral Presentation (Tuesday, February 25, Session #11 – Emerging Opportunities in Proteomics, 1:40 PM – 3:00 PM):

  • Abandoning the Quadrupole for MS Fragmentation Analysis: Towards 1,000 Hz Speeds with 100% Ion Utilization Using High Resolution Ion Mobility Precursor Isolation – Daniel DeBord, Ph.D., Chief Technology Officer at MOBILion

Poster Session 1 (Monday, February 24, 4:30 PM6:00 PM):

  • P01.45LB: Characterization of Key Performance Figures of Merit for PAMAF in Proteomics Applications

Poster Session 2 (Tuesday, February 25, 4:30 PM6:00 PM):

  • P05.26LB: Leveraging HRIM for Dual-purpose Feature Definition and Alignment: Validation of Proteomics Workflows for PAMAF Data
  • P08.08LB: A Novel All-Ion Parallel Reaction Monitoring (AI-PRM) methodology for Enhanced Sensitivity and Speed in High Throughput Targeted Proteomics Analysis

Educational Breakfast Seminar (Wednesday, February 26, 7:15 AM – 8:15 AM):

  • High Resolution Ion Mobility for Next Generation Proteomics Analysis – Danel DeBord, Ph.D.
  • Detection of Upregulated Succinylated Peptides from Sirtuin 5 Knockout Mice – Birgit Schilling, Ph.D.

MOBILion is exhibiting at booth number 18 and inviting attendees to learn how MOBILion’s PAMAF operation mode is shaping the future of proteomics.

About MOBILion Systems, Inc.
MOBILion Systems is Revealing What Others Leave Unseen®, leading the way in next-generation separation science. We develop advanced tools that more deeply, accurately and efficiently characterize complex samples, driving innovation across the pharmaceutical, food testing, proteomics, and environmental safety industries. Our technology integrates with mass spectrometry, enabling workflows that unravel the most complex analyses, redefining the possibilities of molecular characterization. Learn more at www.mobilionsystems.com.

Media Contact
Jon Yu
MOBILionPR@icrhealthcare.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mobilion-systems-to-present-advanced-proteomics-capabilities-with-new-pamaf-operating-mode-at-us-hupo-2025-302375028.html

SOURCE MOBILion Systems

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

2 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

2 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago